Dataset Exner et al: mTOR inhibitor as radiosensitizers in neuroendocrine neoplasms
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Dataset Exner et al: mTOR inhibitor as radiosensitizers in neuroendocrine neoplasms
应用场景：
创建时间：
2020-06-30
相关数据集
Min Long_characteristics，octreotide application of TSHomas_Supplemental Tables and Figures
Supplemental tables and figures for the clinical characteristics and octreotide preoperative application value of TSHomas
NIAID Data Ecosystem210
Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis
Small cell carcinoma of the cervix (SCCC) is a rare primary neuroendocrine cervical carcinoma with a high degree of invasiveness. SCCC is prone to early-stage lymph node and distant metastases and cha
Figshare2018-04-12 更新60
Supplementary Material for: External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
Introduction: Somatostatin analogs (SSA) prolong progression-free survival (PFS) in patients with well-differentiated gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). However, the eligibili
Figshare2021-04-29 更新30
Results for Hepcidin-25 before and after six month treatment of prolactinoma with dopamine agonist therapy [23].
Results for Hepcidin-25 before and after six month treatment of prolactinoma with dopamine agonist therapy [23].
Figshare2016-02-22 更新100
Additional file 1: Table S1. of Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice
Regulation patterns for the 96 transcripts regulated both after 177Lu-octreotate monotherapy and after combination therapy with sonidegib and 177Lu-octreotate. (XLS 40 kb)
Figshare2017-08-09 更新50
